Measurement of electrical skin impedance of dermal-visceral zones as a diagnostic tool for disorders of the immune system

Lupus

Volumn 15, Issue 7, 2006, Pages 457-461

  Gerosa, M ^a   Zimlichman, E ^b   Ventura, D ^a   Fanelli, V ^a   Riboldi, P ^a   Meroni, Pier Luigi ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Allergic diseases; Medex screen; Non conventional medicine; Skin impedance; Systemic autoimmune diseases

Indexed keywords

ADULT; ALLERGIC DISEASE; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMIS; DEVICE; DIAGNOSTIC TEST; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; NEUROPHYSIOLOGY; PHYSICAL EXAMINATION; PHYSICIAN; PRIORITY JOURNAL; REFLEXOLOGY; RELIABILITY; SENSITIVITY AND SPECIFICITY; SKIN CONDUCTANCE; VISCERA;

ADULT; AUTOIMMUNE DISEASES; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DOUBLE-BLIND METHOD; ELECTRIC IMPEDANCE; FEMALE; HUMANS; HYPERSENSITIVITY; LINEAR MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SKIN;

EID: 33746644241     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2333oa     Document Type: Article

References (29)

1. American Medical Association. Periodic health examination: a manual for physicians. American Medical Association, 1947.
2. American Medical Association. Medical evaluations of healthy persons. Council on Scientific Affairs. JAMA 1983; 249: 1626-1633.
3. Lawrence RS, Mickalide AD. Preventive services in clinical practice: designing the periodic health examination. JAMA 1987; 257: 2205-2207.
4. Zimlichman E, Lahad A, Aron-Maor A, Kanevsky A, Shoenfeld Y. Measurement of electrical skin impedance of derma-visceral zones as a diagnostic tool for inner organ pathologies: a blinded preliminary evaluation of a new technique. IMAJ 2005; 7: 631-634.
5. Akeyson EW, Schramm LP. Splanchnic and somatic afferent convergence on cervical spinal neurons of the rat. Am J Physiol 1994; 266: R268-R276.
6. Katter JT, Dado RJ, Kostarczyk E, Giesler Jr GJ. Spinothalamic and spinohypothalamic tract neurons in the sacral spinal cord of rats. II. Responses to cutaneous and visceral stimuli. J Neurophysiol 1996; 75: 2606-2628.
7. Brown PB, Millecchia R, Lawson JJ, Stephens S, Harton P, Culberson JC. Dorsal horn spatial representation of simple cutaneous stimuli. J Neurophysiol 1998; 79: 983-998.
8. Patent number US 10/210, 223. Non-invasive method for internal diseases' diagnosis.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. Smolen J, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum 1998; 41: 768-777.
11. Vitali C. Classification criteria for Sjogren's sindrome. Ann Rheum Dis 2003; 62: 94-95.
12. Lonzetti LS, Joyal F, Raynauld JP et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-736.
13. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
15. Valentine PM. Clinical practice. Allergic rhinitis. N Engl J Med 2005; 353: 1934-1944.
16. Global initiative for Asthma. Global strategy for asthma management and prevention. NIH Publication number 02-3659, 2002.
17. Behrendt H. Atopic eczema and allergy. Curr Allergy Rep 2001; 1: 39-43.
18. Nowak-Wegrzyn A, Sampson HA. Adverse reactions to foods. Med Clin North Am 2006; 90: 97-127.
19. Solensky R. Drug hypersensitivity. Med Clin North Am 2006; 90: 233-260.
20. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
21. Hawa M, Beyan H, Leslie RD. Principles of autoantibodies as disease-specific markers. Autoimmunity 2004; 37: 253-256.
22. Scofield RH. Autoantibodies as predictors of disease. Lancet 2004; 363: 1544-1546.
23. Israeli E, Grotto I, Gilburd B et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54: 1232-1236.
24. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
25. Weetman AP. Autoimmune thyroid disease. Autoimmunity 2004; 37: 337-340.
26. Kisand KE, Metskula K, Kisand KV, Kivik T, Gershwin ME, Uibo R. The follow-up of asymptomatic persons with antibodies to pyryvate dehydeogenase in adult population samples. J Gastroenterol 2001; 36: 248-254.
27. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis. A study of serial measurements in blood donors. Arthritis and Rheum 2004; 50: 380-386.
28. Smeenk RJT, Berden JHM, Swaak AJG. dsDNA autoantibodies. In Peter JB, Shoenfeld Y eds. Autoantibodies. Elsevier, 1996: 227-235.
29. Shmerling RH, Delbanco TL. The rheumatoid factor: an analysis of clinical utility. Am J Med 1991; 91: 528-534.